Life sciences stories
EY-Parthenon says dealmaking is shifting towards AI and technology as 87% of UK chief executives expect their M&A appetite to rise.
The brownfield deal could ease capacity pressure in London, where cloud providers and AI users are competing for scarce land and power.
Yet only 15 per cent have deployed OT-specific visibility tools, even as cyber incidents have already disrupted critical systems for most respondents.
The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.
Poor data quality has been slowing enterprise AI roll-outs, prompting Denodo to link live governed data to AWS agentic tools across multiple services.
The purchase will add more than 1,000 Azure engineers and AI specialists as NTT Data targets larger enterprise roll-outs on Microsoft cloud tools.
The consultancy is betting on growing demand for better use of planning software as companies seek tighter inventory control and more reliable forecasting.
QuEra survey finds quantum buyers and backers are demanding stronger proof of value, even as 46% of organisations expect budgets to stay flat.
AI in life sciences is boosting workflows rather than replacing scientists, as firms navigate regulation, data risks and uneven adoption across markets.
Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.
The new tools give life sciences finance teams clearer trial spending forecasts and scenario planning after a USD $24 million Series A round.
The range is set to reach pharmacy shelves next month, as EZZ seeks to tap demand for evidence-backed women’s wellness products.
Bookings surged 21% in the first quarter, prompting Cognizant to raise its adjusted operating margin outlook and back annual revenue guidance.
Business users could get governed AI support inside analytics workflows as SAS adds copilots, agents and open-standard connectors to Viya.
Healthtech startups are finding it harder to scale as weaker exits and tighter liquidity help drive Canadian VC investment down to CAD $1 billion in 2025.
The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.
AI adoption is pushing firms to use external support to bridge skills gaps, modernise systems and reduce cyber risk as projects move into production.
Federal buyers of AI and HPC systems will gain wider access to Cornelis’s CN5000 platform through new partners ASI Corp, CTG Federal and TVAR Solutions.
Canada’s health tech sector is struggling to turn strong research into commercial scale, as panellists split over whether policy or private capital should lead.
As India’s AI boom accelerates, investors are being urged to weigh trust, inclusion and long-term value alongside growth and scale.